Skip to main content

Reneo Pharmaceuticals, Inc. (RPHM)

NASDAQ: RPHM · IEX Real-Time Price · USD
5.58
+0.16 (2.95%)
Mar 29, 2023, 4:30 PM EDT - Market closed

Stock Price Forecast

According to 12 stock analysts, the average 12-month stock price forecast for RPHM stock is $25.76, which predicts an increase of 361.65%. The lowest target is $17.17 and the highest is $32.55. On average, analysts rate RPHM stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $17.17 $25.76 $27.03 $32.55
Change +207.71% +361.65% +384.41% +483.33%

Analyst Ratings

The average analyst rating for RPHM stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '22Nov '22Dec '22Jan '23Feb '23Mar '23
Strong Buy 666666
Buy 555555
Hold 111111
Sell 000000
Strong Sell 000000
Total 121212121212

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
9.49M
EPS This Year
-2.34
from -2.12
EPS Next Year
-2.01
from -2.34
Year 201920202021202220232024202520262027
Revenue
-----9.49M84.36M472.85M620.25M
Revenue Growth
------
788.60%
460.55%
31.17%
EPS
-6.38-9.60-2.19-2.12-2.34-2.01-0.555.406.30
EPS Growth
--------
16.70%
No. Analysts ----86655

Revenue Forecast

Revenue 20232024202520262027
High n/a 19.5M 110.3M 1.0B 1.1B
Avg n/a 9.5M 84.4M 472.9M 620.3M
Low n/a n/a 60.8M 189.7M 328.2M

Revenue Growth

Revenue Growth 20232024202520262027
High - -
1,061.4%
1,117.5%
130.1%
Avg - -
788.6%
460.5%
31.2%
Low - -
540.1%
124.9%
-30.6%

EPS Forecast

EPS 20232024202520262027
High -2.18 -2.07 0.21 12.66 8.98
Avg -2.34 -2.01 -0.55 5.40 6.30
Low -2.49 -1.93 -1.31 0.82 3.78

EPS Growth

EPS Growth 20232024202520262027
High - - - -
66.4%
Avg - - - -
16.7%
Low - - - -
-29.9%
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.